• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

钠-葡萄糖共转运蛋白 2 抑制剂坎格列净减轻大鼠血管缺血/再灌注损伤后的内皮功能障碍。

The Sodium-Glucose Cotransporter-2 Inhibitor Canagliflozin Alleviates Endothelial Dysfunction Following Vascular Ischemia/Reperfusion Injury in Rats.

机构信息

Department of Cardiac Surgery, University Hospital Heidelberg, 69120 Heidelberg, Germany.

Heart and Vascular Center, Semmelweis University, 1122 Budapest, Hungary.

出版信息

Int J Mol Sci. 2021 Jul 21;22(15):7774. doi: 10.3390/ijms22157774.

DOI:10.3390/ijms22157774
PMID:34360539
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC8345991/
Abstract

Vascular ischemia/reperfusion injury (IRI) contributes to graft failure and adverse clinical outcomes following coronary artery bypass grafting. Sodium-glucose-cotransporter (SGLT)-2-inhibitors have been shown to protect against myocardial IRI, irrespective of diabetes. We hypothesized that adding canagliflozin (CANA) (an SGLT-2-inhibitor) to saline protects vascular grafts from IRI. Aortic rings from non-diabetic rats were isolated and immediately mounted in organ bath chambers (control, n = 9-10 rats) or underwent cold ischemic preservation in saline, supplemented either with a DMSO vehicle (IR, n = 8-10 rats) or 50µM CANA (IR + CANA, n = 9-11 rats). Vascular function was measured, the expression of 88 genes using PCR-array was analyzed, and feature selection using machine learning was applied. Impaired maximal vasorelaxation to acetylcholine in the IR-group compared to controls was significantly ameliorated by CANA (IR 31.7 ± 3.2% vs. IR + CANA 51.9 ± 2.5%, < 0.05). IR altered the expression of 17 genes. , , , , , , , and have been found to have the highest interaction. Compared to controls, IR significantly upregulated the mRNA expressions of and , which were reduced by 1.5- and 1.75-fold with CANA, respectively. CANA significantly prevented the upregulation of Cd40, downregulated NoxO1 gene expression, decreased ICAM-1 and nitrotyrosine, and increased PECAM-1 immunoreactivity. CANA alleviates endothelial dysfunction following IRI.

摘要

血管缺血/再灌注损伤(IRI)是导致冠状动脉旁路移植术后移植物失败和不良临床结局的原因之一。钠-葡萄糖共转运蛋白(SGLT)-2 抑制剂已被证明可预防心肌 IRI,无论是否患有糖尿病。我们假设在生理盐水基础上加用卡格列净(SGLT-2 抑制剂)可以保护血管移植物免受 IRI。从非糖尿病大鼠中分离出主动脉环,并立即将其安装在器官浴槽室中(对照组,n = 9-10 只大鼠)或在生理盐水中进行冷缺血保存,补充 DMSO 载体(IR 组,n = 8-10 只大鼠)或 50µM 卡格列净(IR + CANA 组,n = 9-11 只大鼠)。测量血管功能,使用 PCR 阵列分析 88 个基因的表达,并应用机器学习进行特征选择。与对照组相比,IR 组乙酰胆碱诱导的最大血管舒张功能受损,CANA 显著改善(IR 组 31.7 ± 3.2% vs. IR + CANA 组 51.9 ± 2.5%,<0.05)。IR 改变了 17 个基因的表达。 、 、 、 、 、 、 和 被发现具有最高的相互作用。与对照组相比,IR 显著上调了 和 的 mRNA 表达,CANA 分别将其下调了 1.5-和 1.75 倍。CANA 可显著预防 Cd40 的上调,下调 NoxO1 基因表达,减少 ICAM-1 和硝基酪氨酸,并增加 PECAM-1 免疫反应性。CANA 可减轻 IRI 后的内皮功能障碍。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8366/8345991/0be3d24218f8/ijms-22-07774-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8366/8345991/76a737c5ba84/ijms-22-07774-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8366/8345991/3f83047d4ca4/ijms-22-07774-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8366/8345991/e22875267bc5/ijms-22-07774-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8366/8345991/0160965b4288/ijms-22-07774-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8366/8345991/8dfe12e2fea5/ijms-22-07774-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8366/8345991/0be3d24218f8/ijms-22-07774-g006.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8366/8345991/76a737c5ba84/ijms-22-07774-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8366/8345991/3f83047d4ca4/ijms-22-07774-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8366/8345991/e22875267bc5/ijms-22-07774-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8366/8345991/0160965b4288/ijms-22-07774-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8366/8345991/8dfe12e2fea5/ijms-22-07774-g005.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/8366/8345991/0be3d24218f8/ijms-22-07774-g006.jpg

相似文献

1
The Sodium-Glucose Cotransporter-2 Inhibitor Canagliflozin Alleviates Endothelial Dysfunction Following Vascular Ischemia/Reperfusion Injury in Rats.钠-葡萄糖共转运蛋白 2 抑制剂坎格列净减轻大鼠血管缺血/再灌注损伤后的内皮功能障碍。
Int J Mol Sci. 2021 Jul 21;22(15):7774. doi: 10.3390/ijms22157774.
2
Acute canagliflozin treatment protects against in vivo myocardial ischemia-reperfusion injury in non-diabetic male rats and enhances endothelium-dependent vasorelaxation.急性坎格列净治疗可预防非糖尿病雄性大鼠体内心肌缺血再灌注损伤,并增强内皮依赖性血管舒张功能。
J Transl Med. 2019 Apr 16;17(1):127. doi: 10.1186/s12967-019-1881-8.
3
Conditioned Medium from Mesenchymal Stem Cells Alleviates Endothelial Dysfunction of Vascular Grafts Submitted to Ischemia/Reperfusion Injury in 15-Month-Old Rats.骨髓间充质干细胞条件培养液减轻 15 月龄大鼠缺血/再灌注损伤血管移植物内皮功能障碍。
Cells. 2021 May 17;10(5):1231. doi: 10.3390/cells10051231.
4
Mesenchymal stem cell-derived conditioned medium protects vascular grafts of brain-dead rats against in vitro ischemia/reperfusion injury.间充质干细胞条件培养基可保护脑死亡大鼠的血管移植物免受体外缺血/再灌注损伤。
Stem Cell Res Ther. 2021 Feb 24;12(1):144. doi: 10.1186/s13287-021-02166-3.
5
Graft Preservation Solution DuraGraft Alleviates Vascular Dysfunction Following In Vitro Ischemia/Reperfusion Injury in Rats.移植保存液DuraGraft减轻大鼠体外缺血/再灌注损伤后的血管功能障碍。
Pharmaceuticals (Basel). 2021 Oct 9;14(10):1028. doi: 10.3390/ph14101028.
6
Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice.卡格列净可预防载脂蛋白 E 缺陷小鼠的糖尿病血管功能障碍。
J Atheroscler Thromb. 2020 Nov 1;27(11):1141-1151. doi: 10.5551/jat.52100. Epub 2020 Feb 26.
7
Sodium-glucose cotransporter 2 inhibitor canagliflozin alleviates vascular calcification through suppression of nucleotide-binding domain, leucine-rich-containing family, pyrin domain-containing-3 inflammasome.钠-葡萄糖协同转运蛋白 2 抑制剂卡格列净通过抑制核苷酸结合域、富含亮氨酸重复家族、吡咯烷酮域-3 炎性小体缓解血管钙化。
Cardiovasc Res. 2023 Oct 24;119(13):2368-2381. doi: 10.1093/cvr/cvad119.
8
Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells.坎格列净对脂多糖刺激的人冠状动脉内皮细胞中己糖激酶 II 的新型抗炎作用。
Cardiovasc Drugs Ther. 2021 Dec;35(6):1083-1094. doi: 10.1007/s10557-020-07083-w. Epub 2020 Oct 13.
9
Canagliflozin impairs blood reperfusion of ischaemic lower limb partially by inhibiting the retention and paracrine function of bone marrow derived mesenchymal stem cells.卡格列净部分通过抑制骨髓间充质干细胞的滞留和旁分泌功能来损害缺血性下肢的血液再灌注。
EBioMedicine. 2020 Feb;52:102637. doi: 10.1016/j.ebiom.2020.102637. Epub 2020 Jan 22.
10
Cardiac ischemia-reperfusion injury under insulin-resistant conditions: SGLT1 but not SGLT2 plays a compensatory protective role in diet-induced obesity.胰岛素抵抗状态下的心肌缺血再灌注损伤:SGLT1 而非 SGLT2 在饮食诱导肥胖中发挥代偿性保护作用。
Cardiovasc Diabetol. 2019 Jul 1;18(1):85. doi: 10.1186/s12933-019-0889-y.

引用本文的文献

1
SGLT2 Inhibition Ameliorates Age-Dependent Renovascular Rarefaction.钠-葡萄糖协同转运蛋白2抑制改善年龄依赖性肾血管稀疏。
bioRxiv. 2025 Jun 28:2025.06.27.654312. doi: 10.1101/2025.06.27.654312.
2
Empagliflozin Plays Vasoprotective Role in Spontaneously Hypertensive Rats via Activation of the SIRT1/AMPK Pathway.恩格列净通过激活SIRT1/AMPK通路在自发性高血压大鼠中发挥血管保护作用。
Cells. 2025 Mar 29;14(7):507. doi: 10.3390/cells14070507.
3
Impact of sodium-glucose cotransporter-2 inhibitors on pulmonary vascular cell function and arterial remodeling.

本文引用的文献

1
Canagliflozin protects against sepsis capillary leak syndrome by activating endothelial α1AMPK.卡格列净通过激活内皮细胞 α1AMPK 预防脓毒症毛细血管渗漏综合征。
Sci Rep. 2021 Jul 1;11(1):13700. doi: 10.1038/s41598-021-93156-1.
2
Sodium-glucose cotransporter 2 inhibitors reduce myocardial infarct size in preclinical animal models of myocardial ischaemia-reperfusion injury: a meta-analysis.钠-葡萄糖共转运蛋白 2 抑制剂可减少心肌缺血再灌注损伤的临床前动物模型中的心肌梗死面积:一项荟萃分析。
Diabetologia. 2021 Apr;64(4):737-748. doi: 10.1007/s00125-020-05359-2. Epub 2021 Jan 23.
3
Novel Anti-inflammatory Effects of Canagliflozin Involving Hexokinase II in Lipopolysaccharide-Stimulated Human Coronary Artery Endothelial Cells.
钠-葡萄糖协同转运蛋白2抑制剂对肺血管细胞功能和动脉重塑的影响。
World J Cardiol. 2025 Jan 26;17(1):101491. doi: 10.4330/wjc.v17.i1.101491.
4
In a rat model of bypass DuraGraft ameliorates endothelial dysfunction of arterial grafts.在大鼠旁路 duraGraft 模型中改善了动脉移植物的内皮功能障碍。
Sci Rep. 2024 Jul 2;14(1):15174. doi: 10.1038/s41598-024-66056-3.
5
Protective Mechanisms of SGLTi in Ischemic Heart Disease.SGLTi 在缺血性心脏病中的保护机制。
J Cardiovasc Transl Res. 2024 Oct;17(5):1018-1035. doi: 10.1007/s12265-024-10513-x. Epub 2024 May 20.
6
Effects of hypoxia versus ischaemia on vascular functions of isolated rat thoracic aorta: revisiting the vascular ischaemia/reperfusion model.缺氧与缺血对大鼠离体胸主动脉血管功能的影响:重新审视血管缺血/再灌注模型
Kardiochir Torakochirurgia Pol. 2023 Sep;20(3):173-178. doi: 10.5114/kitp.2023.131952. Epub 2023 Oct 30.
7
Preservation solution Custodiol containing human alpha-1-antitrypsin improves graft recovery after prolonged cold ischemic storage in a rat model of heart transplantation.保存储液 Custodiol 含有人α-1-抗胰蛋白酶可改善延长冷缺血保存后大鼠心脏移植模型中的移植物恢复。
Front Immunol. 2023 Jun 22;14:1155343. doi: 10.3389/fimmu.2023.1155343. eCollection 2023.
8
Editorial to the Special Issue on Sglt2 Inhibitors Vol. 1.关于 Sglt2 抑制剂特刊的社论 第 1 卷。
Int J Mol Sci. 2023 Apr 7;24(8):6873. doi: 10.3390/ijms24086873.
9
Sodium-Glucose Cotransporter 2 Inhibitor Canagliflozin Antagonizes Salt-Sensitive Hypertension Through Modifying Transient Receptor Potential Channels 3 Mediated Vascular Calcium Handling.钠-葡萄糖共转运蛋白 2 抑制剂坎格列净通过调节瞬时受体电位通道 3 介导的血管钙处理拮抗盐敏感性高血压。
J Am Heart Assoc. 2022 Aug 2;11(15):e025328. doi: 10.1161/JAHA.121.025328. Epub 2022 Jul 29.
10
Nitrotyrosine, Nitrated Lipoproteins, and Cardiovascular Dysfunction in Patients with Type 2 Diabetes: What Do We Know and What Remains to Be Explained?2型糖尿病患者中的硝基酪氨酸、硝化脂蛋白与心血管功能障碍:我们了解什么以及还有哪些有待解释?
Antioxidants (Basel). 2022 Apr 27;11(5):856. doi: 10.3390/antiox11050856.
坎格列净对脂多糖刺激的人冠状动脉内皮细胞中己糖激酶 II 的新型抗炎作用。
Cardiovasc Drugs Ther. 2021 Dec;35(6):1083-1094. doi: 10.1007/s10557-020-07083-w. Epub 2020 Oct 13.
4
Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure.恩格列净治疗心力衰竭的心血管和肾脏结局。
N Engl J Med. 2020 Oct 8;383(15):1413-1424. doi: 10.1056/NEJMoa2022190. Epub 2020 Aug 28.
5
A unifying model of glucotoxicity in human renal proximal tubular epithelial cells and the effect of the SGLT2 inhibitor dapagliflozin.在人肾近端肾小管上皮细胞中葡萄糖毒性的统一模型及 SGLT2 抑制剂达格列净的作用。
Int Urol Nephrol. 2020 Jun;52(6):1179-1189. doi: 10.1007/s11255-020-02481-3. Epub 2020 May 2.
6
Gene knockout of the Na-glucose cotransporter SGLT2 in a murine model of acute kidney injury induced by ischemia-reperfusion.基因敲除缺血再灌注损伤诱导的急性肾损伤小鼠模型中 Na-葡萄糖共转运蛋白 SGLT2
Am J Physiol Renal Physiol. 2020 May 1;318(5):F1100-F1112. doi: 10.1152/ajprenal.00607.2019. Epub 2020 Mar 2.
7
Canagliflozin Prevents Diabetes-Induced Vascular Dysfunction in ApoE-Deficient Mice.卡格列净可预防载脂蛋白 E 缺陷小鼠的糖尿病血管功能障碍。
J Atheroscler Thromb. 2020 Nov 1;27(11):1141-1151. doi: 10.5551/jat.52100. Epub 2020 Feb 26.
8
Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction.达格列净治疗射血分数降低的心力衰竭患者。
N Engl J Med. 2019 Nov 21;381(21):1995-2008. doi: 10.1056/NEJMoa1911303. Epub 2019 Sep 19.
9
The CANVAS Program: implications of canagliflozin on reducing cardiovascular risk in patients with type 2 diabetes mellitus.CANVAS 项目:卡格列净对降低 2 型糖尿病患者心血管风险的影响。
Cardiovasc Diabetol. 2019 May 28;18(1):64. doi: 10.1186/s12933-019-0869-2.
10
Gene deletion of the Na-glucose cotransporter SGLT1 ameliorates kidney recovery in a murine model of acute kidney injury induced by ischemia-reperfusion.钠-葡萄糖协同转运蛋白SGLT1的基因缺失改善了缺血再灌注诱导的急性肾损伤小鼠模型中的肾脏恢复情况。
Am J Physiol Renal Physiol. 2019 Jun 1;316(6):F1201-F1210. doi: 10.1152/ajprenal.00111.2019. Epub 2019 Apr 17.